Search

Your search keyword '"Tobe, Sheldon"' showing total 517 results

Search Constraints

Start Over You searched for: Author "Tobe, Sheldon" Remove constraint Author: "Tobe, Sheldon" Publication Type Academic Journals Remove constraint Publication Type: Academic Journals
517 results on '"Tobe, Sheldon"'

Search Results

1. Analysis of the Implementation, User Perspectives, and Feedback From a Mobile Health Intervention for Individuals Living With Hypertension (DREAM-GLOBAL): Mixed Methods Study

2. A Framework for the Study of Complex mHealth Interventions in Diverse Cultural Settings

3. Unpacking the Black Box: A Formative Research Approach to the Development of Theory-Driven, Evidence-Based, and Culturally Safe Text Messages in Mobile Health Interventions

6. Characterizing Hypertension Specialist Care in Canada: A National Survey

9. Outcomes with Finerenone in Participants with Stage 4 CKD and Type 2 Diabetes: A FIDELITY Subgroup Analysis

11. Executive summary of the KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease

13. Impact of Canagliflozin on Kidney and Cardiovascular Outcomes by Type 2 Diabetes Duration: A Pooled Analysis of the CANVAS Program and CREDENCE Trials.

14. Hypertension Canada’s 2020 Comprehensive Guidelines for the Prevention, Diagnosis, Risk Assessment, and Treatment of Hypertension in Adults and Children

19. Hypertension Canada’s 2018 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults and Children

23. Hypertension Canada's 2017 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults

25. Innovative Approaches to Hypertension Control in Low- and Middle-Income Countries

26. Renal denervation for uncontrolled hypertension.

27. Risk of Chronic Kidney Disease in Hospitalized Patients with Hidradenitis Suppurativa.

28. Hypertension Canada's 2016 Canadian Hypertension Education Program Guidelines for Blood Pressure Measurement, Diagnosis, Assessment of Risk, Prevention, and Treatment of Hypertension

31. Cardiovascular and kidney outcomes with canagliflozin according to type 2 diabetes treatment targets at baseline: Data from the CANVAS programme and CREDENCE.

32. Evaluation of visual acuity in dry AMD patients after microcurrent electrical stimulation.

33. Regional and physician specialty–associated variations in the medical management of atherosclerotic renal–artery stenosis

34. The 2015 Canadian Hypertension Education Program Recommendations for Blood Pressure Measurement, Diagnosis, Assessment of Risk, Prevention, and Treatment of Hypertension

36. International Consensus on Standardized Clinic Blood Pressure Measurement – A Call to Action

37. Longitudinal Assessment of the Effect of Atrasentan on Thoracic Bioimpedance in Diabetic Nephropathy: A Randomized, Double-Blind, Placebo-Controlled Trial

39. Relationship of Albuminuria and Renal Artery Stent Outcomes: Results From the CORAL Randomized Clinical Trial (Cardiovascular Outcomes With Renal Artery Lesions)

45. The 2011 Canadian Hypertension Education Program Recommendations for the Management of Hypertension: Blood Pressure Measurement, Diagnosis, Assessment of Risk, and Therapy

47. Identification and Management of Cardiometabolic Risk in Canada: A Position Paper by the Cardiometabolic Risk Working Group (Executive Summary)

48. Cardiometabolic Risk in Canada: A Detailed Analysis and Position Paper by the Cardiometabolic Risk Working Group

49. Prediction of the effect of atrasentan on renal and heart failure outcomes based on short-term changes in multiple risk markers

Catalog

Books, media, physical & digital resources